Home / PDA Letter / Full Article

FDA Takes Close Look at Innovation

by Rebecca Stauffer, PDA

Published On Nov 4, 2019

Industry 4.0. Artificial intelligence. Big data. Even continuous manufacturing. All of these new technologies will drive the future of pharmaceutical and biopharmaceutical manufacturing. Yet questions persist as to how the U.S. FDA and other global regulatory agencies will address these new technologies, leaving some companies reluctant to fully embrace these advances as early adopters.

The contents of "FDA Takes Close Look at Innovation" are available to PDA members. Please sign up or log in to read the full article.